TNF and cancer: Cancer therapy induces the production of reactive oxygen species that in turn incite an inflammatory response by activating nuclear factor kappa B and amplifying TNF-α, which results in the disruption of the epithelial cell barrier and translocation of colonizing bacteria [98].